D. Collen

Molecular Biology · 2001–2007

A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 41 citations into it
• Cancer Research — 17 citations into it

Whom D. Collen trusts

Their strongest outbound trust, strongest first, inferred from their citations.

1. Peter Carmeliet (in Molecular Biology)

Papers from D. Collen's perspective

Ordered by how strongly the researchers D. Collen trusts endorse each paper. Same corpus, a different order for every researcher.

1. Angiopoietin-1 protects the adult vasculature against plasma leakage (Nature Medicine)
2. Mechanisms of angiogenesis and arteriogenesis (Nature Medicine)
3. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. (Cancer Cell)
4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
5. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. (American Journal of Physiology - Cell Physiology)
6. Tumour-educated macrophages promote tumour progression and metastasis (Nature Reviews. Cancer)
7. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. (Journal of Clinical Investigation)
8. Replication validity of genetic association studies (Nature Genetics)
9. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 (Nature Medicine)
10. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. (Journal of Clinical Oncology)

Their papers

• Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 (2002) — 1,130 citations
• Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. (2007) — 805 citations
• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions (2001) — 1,746 citations
• Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 (2003) — 813 citations
• Molecular mechanisms of blood vessel growth. (2001) — 1,071 citations
• VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death (2003) — 904 citations
• Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration (2001) — 1,055 citations